← Open Payments lookup

MELISSA EIGENBRODE: Open Payments

NPI 1740784180 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,500 in 63 payments from 25 companies in 2025. Trend: 2023 $963 · 2024 $2,185 · 2025 $1,500

Food & beverage: $1,500
CompanyPaymentsAmount
Janssen Biotech, Inc.11$317
Ardelyx, Inc.3$144
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$135
ABBVIE INC.6$117
Intercept Pharmaceuticals, Inc.4$93
AstraZeneca Pharmaceuticals LP4$82
QOL Medical, LLC3$78
Madrigal Pharmaceuticals3$61
GENZYME CORPORATION2$54
Takeda Pharmaceuticals U.S.A., Inc.3$54

Products named: TREMFYA, IBSRELA, XIFAXAN, OCALIVA, DUPIXENT, Sucraid, REZDIFFRA, ENTYVIO.

Industry payments across MD — which companies pay providers there.